in
  1. Snyder R, Berns S. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease. Seminars in Dialysis. 2004;17;365-370.[abstract]
  2. Wulffele MG, KooyA, LeherP, BetsD, Ogterop JC, Borger vann der Burg B, Donker AJ, Stehouwer CD. Combination of insulin and metformin in the treatment of type 2 diabetes. Diabetes Care. 2002 Dec; 25 (12): 2133-40.[abstract]
  3. Geisen K, Vegh A, Krause E, Papp JG. Cardiovascular effects of conventional sulfonylureas and glimepiride. Horm Metab Res. 1996;28:496-507. [abstract]
  4. Bijlstra PJ, Lutterman JA, Russel FG, et al. Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans. Diabetologia. 1996;39:1083-90. [abstract]
  5. Mocanu MM, Maddock, HL, Baxter, GF, et al. Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide. Circulation. 2001;103:3111-6. [abstract]

 

Copyright © 2010, 2011  Perelman School of Medicine at the University of Pennsylvania Office of Continuing Medical Education & BestPractice CPD, LLC®. All rights reserved.